Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 362

1.

The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.

Lingemann M, Surman S, Amaro-Carambot E, Schaap-Nutt A, Collins PL, Munir S.

J Virol. 2015 Mar;89(6):3318-31. doi: 10.1128/JVI.03148-14. Epub 2015 Jan 14.

PMID:
25589643
2.

Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.

Le Nouën C, Brock LG, Luongo C, McCarty T, Yang L, Mehedi M, Wimmer E, Mueller S, Collins PL, Buchholz UJ, DiNapoli JM.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13169-74. doi: 10.1073/pnas.1411290111. Epub 2014 Aug 25.

3.

A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection.

Dave KA, Norris EL, Bukreyev AA, Headlam MJ, Buchholz UJ, Singh T, Collins PL, Gorman JJ.

Mol Cell Proteomics. 2014 Dec;13(12):3250-69. doi: 10.1074/mcp.M114.041129. Epub 2014 Aug 8.

PMID:
25106423
4.

Effects of naturally occurring six- and twelve-nucleotide inserts on Newcastle disease virus replication and pathogenesis.

Paldurai A, Xiao S, Kim SH, Kumar S, Nayak B, Samal S, Collins PL, Samal SK.

PLoS One. 2014 Aug 5;9(8):e103951. doi: 10.1371/journal.pone.0103951. eCollection 2014.

5.

KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production.

Pabbisetty SK, Rabacal W, Maseda D, Cendron D, Collins PL, Hoek KL, Parekh VV, Aune TM, Sebzda E.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9579-84. doi: 10.1073/pnas.1323493111. Epub 2014 Jun 16.

6.

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens.

Kim SH, Paldurai A, Xiao S, Collins PL, Samal SK.

Vaccine. 2014 Jul 31;32(35):4428-35. doi: 10.1016/j.vaccine.2014.06.061. Epub 2014 Jun 23.

PMID:
24968158
7.

Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis.

Paldurai A, Kim SH, Nayak B, Xiao S, Shive H, Collins PL, Samal SK.

J Virol. 2014 Aug;88(15):8579-96. doi: 10.1128/JVI.00666-14. Epub 2014 May 21.

8.

Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity.

Dhanda AD, di Mambro AJ, Hunt VL, McCune CA, Dayan CM, Dick AD, Lee RW, Collins PL.

Hepatology. 2015 Mar;61(3):1099. doi: 10.1002/hep.27211. Epub 2014 Jul 31. No abstract available.

PMID:
24811769
9.

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

Liesman RM, Buchholz UJ, Luongo CL, Yang L, Proia AD, DeVincenzo JP, Collins PL, Pickles RJ.

J Clin Invest. 2014 May;124(5):2219-33. doi: 10.1172/JCI72948. Epub 2014 Apr 8.

10.

Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Le Nouën C, Hillyer P, Brock LG, Winter CC, Rabin RL, Collins PL, Buchholz UJ.

J Virol. 2014 Jun;88(11):6453-69. doi: 10.1128/JVI.03261-13. Epub 2014 Mar 26.

11.

Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Walsh KB, Teijaro JR, Brock LG, Fremgen DM, Collins PL, Rosen H, Oldstone MB.

J Virol. 2014 Jun;88(11):6281-93. doi: 10.1128/JVI.00464-14. Epub 2014 Mar 26.

12.

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.

Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.

J Virol. 2014 Apr;88(8):4237-50. doi: 10.1128/JVI.03481-13. Epub 2014 Jan 29.

13.

Live-attenuated respiratory syncytial virus vaccines.

Karron RA, Buchholz UJ, Collins PL.

Curr Top Microbiol Immunol. 2013;372:259-84. doi: 10.1007/978-3-642-38919-1_13.

PMID:
24362694
14.

Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Collins PL, Fearns R, Graham BS.

Curr Top Microbiol Immunol. 2013;372:3-38. doi: 10.1007/978-3-642-38919-1_1.

PMID:
24362682
15.

Is liver biopsy necessary in the management of alcoholic hepatitis?

Dhanda AD, Collins PL, McCune CA.

World J Gastroenterol. 2013 Nov 28;19(44):7825-9. doi: 10.3748/wjg.v19.i44.7825. Review.

16.

Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus.

Kim SH, Xiao S, Paldurai A, Collins PL, Samal SK.

J Gen Virol. 2014 Feb;95(Pt 2):331-6. doi: 10.1099/vir.0.055285-0. Epub 2013 Nov 6.

17.

Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques.

Khattar SK, Nayak B, Kim SH, Xiao S, Samal S, Paldurai A, Buchholz UJ, Collins PL, Samal SK.

PLoS One. 2013 Oct 10;8(10):e75456. doi: 10.1371/journal.pone.0075456. eCollection 2013.

18.

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.

Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group.

Vaccine. 2013 Nov 19;31(48):5706-12. doi: 10.1016/j.vaccine.2013.09.046. Epub 2013 Oct 5.

19.

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.

Khattar SK, Samal S, LaBranche CC, Montefiori DC, Collins PL, Samal SK.

PLoS One. 2013 Oct 1;8(10):e78521. doi: 10.1371/journal.pone.0078521. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/670112f8-b4fd-4622-8a8c-203dc647f807.

20.

Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.

Kim SH, Wanasen N, Paldurai A, Xiao S, Collins PL, Samal SK.

PLoS One. 2013 Aug 28;8(8):e74022. doi: 10.1371/journal.pone.0074022. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk